Gerresheimer Expects Around 9% Growth in 2016

DUESSELDORF, Germany, February 11, 2016 /PRNewswire/ --

 

• Revenues in financial year 2015 up 6.8% to EUR 1,377.2m 
• Adjusted EBITDA climbs to EUR 277.9m  
• Adjusted earnings per share rise 18.0% to EUR 3.41 
• Proposed dividend of EUR 0.85 per share (2014: EUR 0.75 per share) 
• Centor acquisition, sale of glass tubing business and refinancing successfully completed 
• Approximately 9% revenue growth expected in 2016, with 4% to 5% on organic basis 
• Adjusted EBITDA expected for 2016 at approximately EUR 320m 

Gerresheimer AG, one of the leading partners to the pharma and healthcare industry worldwide, brought financial year 2015 to a successful close and sees strong growth prospects for the years ahead. "2015 was not only a successful but also an important year for us. In Centor, we successfully acquired a market-leading and profitable company in the USA. Similarly important was the sale of the glass tubing production activities, with which we further sharpened our focus on pharmaceutical packaging and made our business less capital-intensive. We are successfully implementing our strategy, and I look forward with great confidence to the years ahead," said Uwe Röhrhoff, CEO of Gerresheimer AG. 

Pharmaceutical packaging manufacturer Gerresheimer boosted revenues by 6.8% to EUR 1,377.2m in financial year 2015 (December 1, 2014 to November 30, 2015). On an organic basis, revenues increased by 1.5%, within the 1% to 3% target corridor. Notable revenue growth was generated with pharmaceutical plastic packaging as well as products for safe and simple drug delivery such as insulin pens, skin-prick aids for diabetics and asthma inhalers. Business with pharmaceutical primary packaging glass picked up in the course of the year after a slow start in the USA. The market for premium cosmetic glass packaging developed well, largely driven by the trend toward elaborate design and the associated finishing processes. Revenues with laboratory glassware, which is primarily sold in the USA, increased solely as a result of exchange rate changes. At constant exchange rates revenues showed a slight decrease.